BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23352041)

  • 1. In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles.
    Nogueira DR; Tavano L; Mitjans M; Pérez L; Infante MR; Vinardell MP
    Biomaterials; 2013 Apr; 34(11):2758-72. PubMed ID: 23352041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion of a pH-responsive amino acid-based amphiphile in methotrexate-loaded chitosan nanoparticles as a delivery strategy in cancer therapy.
    Nogueira DR; Scheeren LE; Macedo LB; Marcolino AI; Pilar Vinardell M; Mitjans M; Rosa Infante M; Farooqi AA; Rolim CM
    Amino Acids; 2016 Jan; 48(1):157-68. PubMed ID: 26306845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
    Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
    Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-tripolyphosphate nanoparticles functionalized with a pH-responsive amphiphile improved the in vitro antineoplastic effects of doxorubicin.
    Nogueira-Librelotto DR; Scheeren LE; Vinardell MP; Mitjans M; Rolim CMB
    Colloids Surf B Biointerfaces; 2016 Nov; 147():326-335. PubMed ID: 27543694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
    Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
    ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobionic acid-modified thymine-chitosan nanoparticles as potential carriers for methotrexate delivery.
    Wang J; Zhang Z; Ai Y; Liu F; Chen MM; Liu D
    Carbohydr Res; 2021 Mar; 501():108275. PubMed ID: 33657498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly (ɛ-Caprolactone) Nanoparticles with pH-Responsive Behavior Improved the In Vitro Antitumor Activity of Methotrexate.
    Macedo LB; Nogueira-Librelotto DR; de Vargas J; Scheeren LE; Vinardell MP; Rolim CMB
    AAPS PharmSciTech; 2019 Apr; 20(5):165. PubMed ID: 30993464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles incorporating pH-responsive surfactants as a viable approach to improve the intracellular drug delivery.
    Nogueira DR; Scheeren LE; Pilar Vinardell M; Mitjans M; Rosa Infante M; Rolim CM
    Mater Sci Eng C Mater Biol Appl; 2015 Dec; 57():100-6. PubMed ID: 26354244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-Sensitive chitosan-tripolyphosphate nanoparticles increase doxorubicin-induced growth inhibition of cervical HeLa tumor cells by apoptosis and cell cycle modulation.
    Nogueira-Librelotto DR; Scheeren LE; Macedo LB; Vinardell MP; Rolim CMB
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110897. PubMed ID: 32126359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery.
    Naghibi Beidokhti HR; Ghaffarzadegan R; Mirzakhanlouei S; Ghazizadeh L; Dorkoosh FA
    AAPS PharmSciTech; 2017 Jan; 18(1):115-129. PubMed ID: 26896317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and formulation of methotrexate (MTX) conjugated LaF3:Tb(3+)/chitosan nanoparticles for targeted drug delivery applications.
    Mangaiyarkarasi R; Chinnathambi S; Aruna P; Ganesan S
    Biomed Pharmacother; 2015 Feb; 69():170-8. PubMed ID: 25661354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity.
    Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X
    Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose cryoprotectant affects glutathione-responsive antitumor drug release from polysaccharide nanoparticles.
    Curcio M; Blanco-Fernández B; Costoya A; Concheiro A; Puoci F; Alvarez-Lorenzo C
    Eur J Pharm Biopharm; 2015 Jun; 93():281-92. PubMed ID: 25917641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface functionalization of methotrexate-loaded chitosan nanoparticles with hyaluronic acid/human serum albumin: Comparative characterization and in vitro cytotoxicity.
    Hashad RA; Ishak RA; Geneidi AS; Mansour S
    Int J Pharm; 2017 Apr; 522(1-2):128-136. PubMed ID: 28279742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.
    Lan JS; Qin YH; Liu L; Zeng RF; Yang Y; Wang K; Ding Y; Zhang T; Ho RJY
    Int J Nanomedicine; 2021; 16():1775-1787. PubMed ID: 33692622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of pH-sensitive lysozyme/pectin nanogel for tumor methotrexate delivery.
    Lin L; Xu W; Liang H; He L; Liu S; Li Y; Li B; Chen Y
    Colloids Surf B Biointerfaces; 2015 Feb; 126():459-66. PubMed ID: 25601095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: synthesis, characterization and in vitro cytotoxicity evaluation.
    Jeevitha D; Amarnath K
    Colloids Surf B Biointerfaces; 2013 Jan; 101():126-34. PubMed ID: 22796782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery.
    Rasouli S; Davaran S; Rasouli F; Mahkam M; Salehi R
    Drug Deliv; 2014 May; 21(3):155-63. PubMed ID: 24107075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of Doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery.
    Unsoy G; Khodadust R; Yalcin S; Mutlu P; Gunduz U
    Eur J Pharm Sci; 2014 Oct; 62():243-50. PubMed ID: 24931189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH/redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate.
    Gao C; Liu T; Dang Y; Yu Z; Wang W; Guo J; Zhang X; He G; Zheng H; Yin Y; Kong X
    Carbohydr Polym; 2014 Oct; 111():964-70. PubMed ID: 25037437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.